PET/MRI in cancer patients: first experiences and vision from Copenhagen

Research output: Contribution to journalJournal articleResearchpeer-review

Andreas Kjær, Annika Loft, Ian Law, Anne Kiil Berthelsen, Lise Borgwardt, Johan Löfgren, Camilla Bardram Johnbeck, Adam Espe Hansen, Sune Keller, Søren Holm, Liselotte Højgaard

Combined PET/MRI systems are now commercially available and are expected to change the medical imaging field by providing combined anato-metabolic image information. We believe this will be of particular relevance in imaging of cancer patients. At the Department of Clinical Physiology, Nuclear Medicine & PET at Rigshospitalet in Copenhagen we installed an integrated PET/MRI in December 2011. Here, we describe our first clinical PET/MR cases and discuss some of the areas within oncology where we envision promising future application of integrated PET/MR imaging in clinical routine. Cases described include brain tumors, pediatric oncology as well as lung, abdominal and pelvic cancer. In general the cases show that PET/MRI performs well in all these types of cancer when compared to PET/CT. However, future large-scale clinical studies are needed to establish when to use PET/MRI. We envision that PET/MRI in oncology will prove to become a valuable addition to PET/CT in diagnosing, tailoring and monitoring cancer therapy in selected patient populations.
Original languageEnglish
JournalMagnetic Resonance Materials in Physics, Biology and Medicine
ISSN0968-5243
DOIs
Publication statusPublished - 2013

ID: 48459230